Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)

Ronan Le Calloch 1 Karine Lacut 2 Christelle Le Gall-Ianotto 3 Emmanuel Nowak 4 Morgane Abiven Adrian Tempescul 5 Florence Dalbies 6 Jean-Richard Eveillard 7 Valérie Ugo 8 Stéphane Giraudier 9 Gaëlle Guillerm 10 Eric Lippert 11 Christian Berthou 6 Jean-Christophe Ianotto 6, 2
1 Service de Médecine Interne et Maladies Infectieuses Quimper
2 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale
3 LNB - Laboratoire de Neurosciences de Brest
4 CIC Brest
5 LBAI - Lymphocyte B et Auto-immunité
6 CHU-Brest-Hemato - CHRU Brest - Service d'Hématologie
7 Institut de cancérologie et d'hématologie
8 UA - Université d'Angers
9 Hôpital Saint-Louis
10 Labo Hémato - BREST - Laboratoire d'hématologie
11 Laboratoire d'hématologie
Document type :
Journal articles
Complete list of metadatas
https://hal.univ-brest.fr/hal-02056217
Contributor : Ghislaine Calvez <>
Submitted on : Monday, March 4, 2019 - 2:43:57 PM
Last modification on : Tuesday, May 7, 2019 - 6:30:12 PM

Identifiers

  • HAL Id : hal-02056217, version 1

Collections

UNIV-BREST | GETBO | UNIV-ANGERS | LIEN | IMMUNO | IBSAM | UNIV-PARIS7 | USPC

Citation

Ronan Le Calloch, Karine Lacut, Christelle Le Gall-Ianotto, Emmanuel Nowak, Morgane Abiven, et al.. Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study). Haematologica, Ferrata Storti Foundation, 2018, 103 (4), pp.607-613. ⟨hal-02056217⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

68

Contact

CCSD